| Preparation of particles for inhalation DA Edwards, RS Langer, R Vanbever, J Mintzes, J Wang, D Chen US Patent 5,985,309, 1999 | 698 | 1999 |
| Skin electroporation for transdermal and topical delivery AR Denet, R Vanbever, V Préat Advanced drug delivery reviews 56 (5), 659-674, 2004 | 683 | 2004 |
| Delivery strategies for sustained drug release in the lungs C Loira-Pastoriza, J Todoroff, R Vanbever Advanced drug delivery reviews 75, 81-91, 2014 | 421 | 2014 |
| Formulation and physical characterization of large porous particles for inhalation R Vanbever, JD Mintzes, J Wang, J Nice, D Chen, R Batycky, R Langer, ... Pharmaceutical research 16, 1735-1742, 1999 | 420 | 1999 |
| Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance C Bosquillon, C Lombry, V Preat, R Vanbever Journal of controlled release 70 (3), 329-339, 2001 | 386 | 2001 |
| The particle has landed—characterizing the fate of inhaled pharmaceuticals JS Patton, JD Brain, LA Davies, J Fiegel, M Gumbleton, KJ Kim, ... Journal of aerosol medicine and pulmonary drug delivery 23 (S2), S-71-S-87, 2010 | 281 | 2010 |
| Transdermal delivery of metoprolol by electroporation R Vanbever, N Lecouturier, V Préat Pharmaceutical research 11, 1657-1662, 1994 | 214 | 1994 |
| Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats C Bosquillon, V Préat, R Vanbever Journal of Controlled Release 96 (2), 233-244, 2004 | 207 | 2004 |
| Introduction of modifying agents into skin by electroporation JC Weaver, T Chen, C Cullander, R Guy, RS Langer, TE Zewert, ... US Patent 5,911,223, 1999 | 207 | 1999 |
| In vivo efficacy and safety of skin electroporation R Vanbever, V Preat Advanced drug delivery reviews 35 (1), 77-88, 1999 | 176 | 1999 |
| Transdermal delivery of fentanyl by electroporation I. Influence of electrical factors R Vanbever, E Le Boulengé, V Préat Pharmaceutical research 13, 559-565, 1996 | 169 | 1996 |
| Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs A Ben-Jebria, D Chen, ML Eskew, R Vanbever, R Langer, DA Edwards Pharmaceutical research 16, 555-561, 1999 | 164 | 1999 |
| Fate of nanomedicines in the lungs J Todoroff, R Vanbever Current Opinion in Colloid & Interface Science 16 (3), 246-254, 2011 | 160 | 2011 |
| Aerosolization properties, surface composition and physical state of spray-dried protein powders C Bosquillon, PG Rouxhet, F Ahimou, D Simon, C Culot, V Préat, ... Journal of Controlled Release 99 (3), 357-367, 2004 | 154 | 2004 |
| Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules C Lombry, DA Edwards, V Préat, R Vanbever American Journal of Physiology-Lung Cellular and Molecular Physiology 286 (5 …, 2004 | 154 | 2004 |
| Preclinical models for pulmonary drug delivery CA Fernandes, R Vanbever Expert opinion on drug delivery 6 (11), 1231-1245, 2009 | 138 | 2009 |
| Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats V Codrons, F Vanderbist, RK Verbeeck, M Arras, D Lison, V Préat, ... Journal of pharmaceutical sciences 92 (5), 938-950, 2003 | 131 | 2003 |
| Transdermal drug delivery RH Guy, J Hadgraft M. Dekker, 2003 | 131 | 2003 |
| Biopotential measurement including electroporation of tissue surface JC Weaver, U Pliquett, R Vanbever, TR Gowrishankar, TE Zewert US Patent 6,085,115, 2000 | 125 | 2000 |
| Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation R Vanbever, G Langers, S Montmayeur, V Preat Journal of controlled release 50 (1-3), 225-235, 1998 | 106 | 1998 |
Veronique PreatProfesseur, Université catholique de Louvain在 uclouvain.be 的电子邮件经过验证
